Hagberg, K. W., Vasilakis-Scaramozza, C. ., Persson, R. ., Neasham, D. ., Kafatos, G. ., & Jick, S. . (2023). Presence of Breast Cancer Information Recorded in United Kingdom Primary Care Databases: Comparison of CPRD Aurum and CPRD GOLD (Companion Paper 1). Clin Epidemiol, 15, 1183–1192. http://doi.org/10.2147/clep.s434795
R. Persson
First name
R.
Last name
Persson
Hagberg, K. W., Vasilakis-Scaramozza, C. ., Persson, R. ., Neasham, D. ., Kafatos, G. ., & Jick, S. . (2023). Correctness and Completeness of Breast Cancer Diagnoses Recorded in UK CPRD Aurum and CPRD GOLD Databases: Comparison to Hospital Episode Statistics and Cancer Registry (Companion Paper 2). Clin Epidemiol, 15, 1193–1206. http://doi.org/10.2147/clep.s434829
Jick, S. ., Vasilakis-Scaramozza, C. ., Persson, R. ., Neasham, D. ., Kafatos, G. ., & Hagberg, K. W. (2023). Use of the CPRD Aurum Database: Insights Gained from New Data Quality Assessments. Clin Epidemiol, 15, 1219–1222. http://doi.org/10.2147/clep.s434832
Vasilakis-Scaramozza, C. ., Hagberg, K. W., Persson, R. ., Kafatos, G. ., Maskell, J. ., Neasham, D. ., & Jick, S. . (2023). Comparison of Rheumatoid Arthritis Information Recorded in UK CPRD Aurum and CPRD GOLD Databases (Companion Paper 3). Clin Epidemiol, 15, 1207–1218. http://doi.org/10.2147/clep.s434831
Vasilakis-Scaramozza, C. ., Hagberg, K. W., Persson, R. ., Yelland, E. ., Williams, T. ., Myles, P. ., & Jick, S. S. (2022). Quality of rheumatoid arthritis recording in United Kingdom Clinical Practice Research Datalink Aurum. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5551
Persson, R. ., Cordey, M. ., Paris, M. ., & Jick, S. . (2022). Safety of Apremilast in Patients with Psoriasis and Psoriatic Arthritis: Findings from the UK Clinical Practice Research Datalink. Drug Saf, 1–9. http://doi.org/10.1007/s40264-022-01235-7
Persson, R. ., Hagberg, K. W., Vasilakis-Scaramozza, C. ., Yelland, E. ., Williams, T. ., Myles, P. ., & Jick, S. S. (2022). Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia Treatments. Clin Epidemiol, 14, 641–652. http://doi.org/10.2147/clep.s360843
Hagberg, K. W., Divan, H. A., Persson, R. ., Nickel, J. C., & Jick, S. S. (2016). Risk of erectile dysfunction associated with use of 5-alpha reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink. Bmj. http://doi.org/10.1136/bmj.i4823
Persson, R. ., Lee, S. ., Yood, M. U., Wagner, M. ., Minton, N. ., Niemcryk, S. ., … Jick, S. . (2019). Multi-database study of multiple sclerosis: identification, validation and description of MS patients in two countries. J Neurol. http://doi.org/10.1007/s00415-019-09238-8
Persson, R. ., & Jick, S. . (2019). Clinical implications of the association between fluoroquinolones and tendon rupture: the magnitude of the effect with and without corticosteroids. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.13879